
|Articles|September 15, 2021
Syneos Health Acquires StudyKIK
Advertisement
Syneos Health has announced the acquisition of StudyKIK, a technology-enabled clinical trial recruitment and retention company. StudyKIK provides eConsent, Telemedicine video calling, Phone Pre-Qualifications, and Patient Retention application solutions. The company manages over 1,000 indication-specific patient community groups and has enrolled more than 5,400 protocols supporting over 3,800 research sites across the globe. The platform encompasses more than 6 million patients through social media.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
2
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
3
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
4
How Sourcing Decisions Shape Site Experience and Study Execution
5




